Buyer Market Demand Explorer

Buyer markets for containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale

A reported trade view for HS 300432, with available observations through 2024.

HS6 300432Coverage 1995-2024Updated 2026-08-14
Explore this product

Largest buyer

USA$1.9B

Buyer markets

200Reported markets

Top market suppliers

35For the largest buyer

Latest global trade

$11.5BYear: 2024

Reported observations

Buyer market evidence

Markets ranked by latest reported import value.

Buyer marketLatest imports5-year growthSuppliersLeading supplier
USA$1.9B+2.3%35France
China$1.1B+4.1%33France
France$922.5M+5.8%43United Kingdom
United Kingdom$640.9M+2.1%40Italy
Germany$604.5M-0%41Italy
Canada$505.6M+6.7%38Sweden
Netherlands$502.1M+34.7%40Ireland
Japan$428.5M-10%23United Kingdom
Russia$283.4M-2.7%25Sweden
Australia$243.3M+5.8%23USA
Spain$240.3M+3.7%26France
Switzerland, Liechtenstein$217.6M+17.3%30Spain
Belgium$216.9M-2.4%42France
Italy$208.4M+5.9%33France
Poland$171.0M+3.2%32Italy
Saudi Arabia$154.0M+1.4%22Sweden
Mexico$149.3M+15.5%26Sweden
Austria$138.6M+13%30Italy
United Arab Emirates$137.3M+9.6%41Sweden
Hungary$118.9M+6.3%25Belgium
Czechia$118.6M+7.6%34India
Romania$116.9M+5.9%26Hungary
Viet Nam$114.1M+8.9%41Belgium
Egypt$101.7M+6.9%22Sweden
Ukraine$82.7M+8.6%32Hungary
Brazil$81.6M+10.1%19Italy
Portugal$80.0M+7.2%25Spain
Sweden$71.1M-1.5%39France
Greece$65.3M+6.6%19Italy
Republic of Korea$64.1M+7.2%22United Kingdom
Thailand$63.0M+4.5%27Spain
Norway$58.3M+15.6%28Denmark
South Africa$57.2M-0.6%24Belgium
Bulgaria$54.9M+5.6%25Italy
Denmark$54.8M-11.2%27Czechia

Market reading

Which countries buy containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale?

USA is the largest reported buyer market in this view, with imports of $1.9B.

How to use this view

Start with the leading rows in the first table, then use the chart to compare buyer-market demand and supplier breadth for containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale. The second table adds a related reported comparison.

Coverage extends to 2024. Missing values are shown as not reported.

Further comparison

Buyer market price evidence

Available reported unit-value observations by buyer market.

Buyer marketYearTrade valueUSD per ton
USA2023$1.7B$208,880.49
France2023$930.3M$312,614.01
China2023$829.6M$140,673.03
Germany2023$605.6M$197,816.96
Japan2023$536.1M$161,370.17
Canada2023$489.7M$180,186.6
United Kingdom2023$475.7M$180,843.45
Netherlands2023$472.6M$136,384.5
Spain2023$277.8M$208,244.07
Russia2023$258.3M$127,134.91
Italy2023$241.0M$182,636
Belgium2023$232.4M$122,848.75
Australia2023$227.7M$171,992.49
Poland2023$199.4M$162,070.59
Switzerland, Liechtenstein2023$196.7M$270,061.97
United Arab Emirates2023$163.0M$135,794.56
Saudi Arabia2023$144.7M$237,816.33
Austria2023$130.8M$301,290.37
Romania2023$129.1M$228,391.06
Mexico2023$126.1M$153,254.31

Explore related views

Continue with another perspective on this product.

Latest observed year: 2024. Page updated 2026-08-14.

Source and date

Reported merchandise-trade observations for HS6 products. Coverage shown on this page: 1995-2024. Updated 2026-08-14.

Definitions

Trade value is reported in current US dollars. Unit value is trade value divided by reported quantity and is shown per metric ton where available. Growth is an annualized or year-on-year calculation from reported values.

Reading the data

“Not reported” means a value was not available for this view. Values can be revised as reporting is updated. See the methodology for coverage and classification details.